Novo-konkurrents diabetes-omsætning bløder også

Det er ikke kun Novo Nordisk, der lider under de vanskelige markedsvilkår for diabetesmedicin i USA. Også franske Sanofi, der blandt andet producerer insulinpræparatet Lantus, må tage n …

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

You must be logged in to post a comment.

Powered by WordPress | Designed by: Premium Themes | Thanks to Free WordPress 4 Themes, Download Premium WordPress Themes and
%d bloggers like this: